Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare Conference
September 10, 2020 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developments
September 01, 2020 16:05 ET
|
Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $25.4 Million -- -- Signed Three New Customers and Project Expansion Orders with Current Customers for $20 Million -- -- Backlog of $60 Million at Quarter-End --...
Avid Bioservices Selected by Mapp Biopharmaceutical, Inc. for Clinical Development of Novel Human Monoclonal Antiviral Antibody
August 26, 2020 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2021 After Market Close on September 1, 2020
August 25, 2020 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Selected By Iovance Biotherapeutics to Lead Process Development Through CGMP Manufacturing of Novel IL-2 Analog, IOV-3001
August 06, 2020 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices and Argonaut Manufacturing Services Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Process Development, Drug Substance Manufacturing and Drug Product Parenteral Manufacturing
July 28, 2020 08:05 ET
|
Avid Bioservices, Inc; Argonaut Manufacturing Services
TUSTIN, Calif. and CARLSBAD, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing...
Cytovance Biologics Announces an Investment in Mass Spectrometry Services
July 15, 2020 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, July 15, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the addition of Mass...
Cytovance Biologics Promotes John Mott to Vice President of Development
July 13, 2020 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, July 13, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the promotion of Dr. John...
Psoriatic Arthritis Treatment Market to Reach $13.74 Bn, By 2026
July 08, 2020 09:15 ET
|
Allied Market Research
Portland, OR, July 08, 2020 (GLOBE NEWSWIRE) -- Allied Market Research recently published a report, titled, “Psoriatic Arthritis Treatment Market by Drug Type (NSAIDs, DMARDs, Biologics, and...
Cytovance Biologics Announces Yuk Chun Chiu as Vice President of Manufacturing Operations
July 06, 2020 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, July 06, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces Yuk Chun Chiu as Vice...